Analyst Research

Report Title Price
Provider: Reuters Investment Profile
Provider: Reuters Investment Profile
Provider: Ford Investor Services, Inc.
Provider: ValuEngine, Inc.

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Bayer AG Confirms FY 2013 Sales Guidance

Thursday, 25 Apr 2013 02:48am EDT 

Bayer AG announced that it confirms its sales forecast for 2013. The Company continues to expect sales for the full year 2013 to increase by 4% to 5% to approximately EUR 41 billion, based on unchanged currency assumptions. According to I/B/E/S Estimates, analysts on average are expecting the Company to report fiscal year 2013 revenue of EUR 41,496.19 million. 

Latest Key Developments in Pharmaceuticals

Company Quote

0.35 +0.35%
11 Jul 2014